Background: CBAVD (Congenital Bilateral Absence of the Vas Deferens), a frequent cause
To date, more than 1,600 genetic changes have been identified in this gene. A combination of severe mutations on both alleles of a patient usually leads to severe forms of classical Cystic Fibrosis (CF). 3 4 Other mutations that retain residual CFTR function (above 10%), result in mild CF or incomplete phenotypes. CBAVD patients carry two mild mutations or are compound heterozygous for a severe and a mild alterations of the CFTR gene. 1 5 Despite extensive testing for point mutations and large rearrangements [6] [7] [8] [9] , a small proportion of alleles still remains unidentified in CBAVD patients. 1 10 Interestingly, we have detected two novel rare (TAAA) n repeats in the IVS9 of the CFTR gene in two CBAVD patients, heterozygous for a variation in the minimal promoter (-33G>A) 11 or for the common CBAVD variant (TG12T5).
Microsatellites, also known as Short Tandem Repeats (STRs), are distributed throughout the genome 12 .
Since the last decade, scientists suggested that alterations in the length of simple DNA repeat sequences might be responsible for diseases, such as myotonic dystrophy type 2 13 and gynecomastia. 14 Accumulating data evidenced that microsatellite variations including tetranucleotides affect regulation of gene expression by inhibiting the transcription of these genes implicated in diseases 15 16 or by altering RNA processing 17 for
STRs detected close to some intron/exon boundaries.
Several microsatellites have been identified in non-coding regions of the CFTR gene. [18] [19] [20] Whereas most are dinucleotides, two tetranucleotides (TAAA) n and (GATT) n repeats have been reported in intronic regions. 18 19 Except for the (TG)mTn polymorphism 4 tracts in the CFTR IVS8, known to dramatically alter the CFTR exon 9 skipping 18 21-25 , the role of repeats in the regulation of CFTR function and expression remains poorly defined.
The aim of this study was to evaluate whether the uncommon -33G>A promoter variant and the (TAAA) 6 and (TAAA) 8 tetranucleotide repeat alterations located deeply within intron 9 may contribute to the CBAVD phenotype. We were also interested in understanding the molecular mechanism by investigating the potential regulatory function of Forkhead box (FOX) transcription factors in the presence of these variants.
Material and methods
Haplotyping IVS9(TAAA)n repeats.
PCR reactions were carried out on 100 ng of human DNA (see primers in Supplementary To perform gene reporter assays, the pGL3B-33A plasmid was generated from pGL3B-WT, pGL3-Basic reporter vector containing the wild-type human CFTR minimal promoter 27 , by site-directed mutagenesis (Stratagene).
The pcDNA3-FOXI1 expression vector was generously gift by Dr. S. Enerbäck (Center of Medical Genetics, Institute of Biomedicine, Göterborg University, Sweden). The AE4-promH1 and AE4-promH3 reporter constructs were kindly provided by Dr. C.A. Hübner (Department of Human Genetics, UKE-Hamburg, Hamburg, Germany).
For hybrid minigene assays, constructs containing the (TAAA) n repeats of the CFTR intron 9
were created as depicted in figure 3 . The human CFTR genomic regions encompassing the 5 exons 9 and 10 with their flanking intronic sequences were amplified in two separated PCRs.
The PCR products were subcloned into the XhoI/NheI digested pSPL3 plasmid, kindly gift by Dr. S. Tuffery-Giraud (Laboratory of Molecular Genetics, Montpellier, France). As positive controls, minigenes containing either a T5 or a T3 allele 22 were generated by directed mutagenesis (Stratagene).
To prepare the gene reporter vectors pGL3C-(TAAA) n , a 1222-base pair fragment spanning the CFTR intron 9 region was generated by PCR from genomic DNA of individuals with (TAAA) 9 , (TAAA) 8 or (TAAA) 6 repeat. The PCR products were restricted with NheI and BglII endonucleases and then ligated into the pGL3-Control reporter vector (Promega)
upstream the SV40 promoter.
To evaluate CFTR mRNA levels, expression plasmids containing either the wild-type or the mutated CFTR minimal promoter upstream the CFTR cDNA (pcDNA3.1-WT and pcDNA3.1-33A, respectively) were constructed. The full-length human CFTR cDNA was excised from the pTG5985 vector, generously given by Transgene SA, with ApaI/XhoI and ligated into the pcDNA3.1(-) expression vector. To drive the expression of the CFTR cDNA, the SV-40 promoter was replaced by the CFTR minimal promoter. For the (TAAA) n repeat, the (TAAA) n intron 9 region is inserted upstream the CFTR minimal promoter in the pcDNA3.1(-) expression vector containing the CFTR cDNA. All the primers are listed in Supplementary 
Reverse-transcriptase PCR and RT-qPCR.
Total RNAs were extracted by using the RNeasy Plus Mini kit (Qiagen). RT were performed as previously described 29 , and cDNAs were amplified with either SD6/SA2/β-actin primers (hybrid minigene) or CFTR/GAPDH (expression vector), by using classical PCR or the LightCycler® 480 Real-Time PCR System (Roche), respectively. All PCR reactions were performed in triplicate in three independent experiments.
Chromatin Immunoprecipitation assays (ChIP)
ChIP assays were performed according to protocols previously described with minor modifications. 29 Prior to harvest, stably transfected HVP cells were cross-linked with formaldehyde. Purified crosslinked chromatin was immunoprecipitated using 3µg of either anti-FOXI1 antibody (AbCam) or anti-HA antibody (Roche), used to control for non-specific binding of DNA. Input and immunoprecipitated DNAs were analyzed using either primers specific of the CFTR minimal promoter or primers amplifying the CFTR intron 9 region containing the (TAAA) n repeat (Supplementary Table 1) , with the LightCycler® 480 RealTime PCR System (Roche). All PCR reactions were performed in triplicate. Experiments are repeated at least three times, averaged and expressed relative to the input signal and to negative control.
Immunoblot analyses
Total whole-cell proteins from transfected HVP cells were analyzed by western blot as previously described. 29 The membranes were incubated overnight with 1:1,000 diluted anti-8 FOXI1 (Ab-Cam) primary antibody in 5% skim milk. The protein levels of the β-actin housekeeping gene were assayed for internal control of protein loading.
Statistical analyses.
Data are expressed as the mean ± SE. Paired comparisons were made using student's t-test using InStat (GraphPad Software, version 3.0). Data were considered statistically significant at p<0.05. Relative intensities of equal areas were compared using Quantity One® quantification analysis software (Bio-Rad).
Results

The -33G>A transition in the CFTR minimal promoter leads to a decreased promoter activity
We first investigated the putative effect of a rare promoter substitution, -33G>A, on both the CFTR transcriptional activity and mRNA levels. We next employed quantitative ChIP analyses to obtain evidence that FOXI1 proteins bind differentially to the mutated CFTR promoter sequence. Because we could not have access to the patient's tissue, ChIP assays were performed using stable HVP cells expressing either the wild-type or the mutated CFTR promoter reporter construct (pGL3B-WT and pGL3B-33A).
The qPCR results reveal that FOXI1 binds to the minimal CFTR promoter in HVP cells with a higher avidity for the mutated promoter ( Figure 2B ).
To assess the functional activity of the FOXI1 factor, we transiently co-transfected the reported. 30 32 Collectively, these data established that FOXI1 inhibits the CFTR promoter activity with a marked effect on the -33A allele.
Genetic analysis of previously undescribed (TAAA)n repeats sequence DNA motif in CFTR IVS9
By scanning microsatellite variability in the CFTR IVS9, in a sample of 254 control chromosomes and 86 chromosomes from CBAVD patients with 1 or 0 CFTR mutation, we identified five tetranucleotide (TAAA) n repeat tracts with number of motifs ranging from 9 to
13. This study showed that the 9-repeats allele is the most frequent ( 'n' the total number of chromosomes
12
We hypothesized that these tetranucleotide repeats, located deeply within intron 9, could influence gene expression. 15 16 33 34 Also, we evaluated the functional importance of the new CBAVD (TAAA) 6 and (TAAA) 8 alleles compared to the most frequent (TAAA) 9 allele in general population.
The (TAAA) n repeat motif does not influence the splicing of CFTR exon 10
To investigate the putative impact of the IVS9 (TAAA) microsatellite on the RNA processing, CFTR exons 9-10 hybrid minigene constructs ( Figure 3A) were transiently transfected into HVP and Hela cells, and the pattern of splicing was analyzed by RT-PCR with the SD6/SA2 primers. In the two tested cell lines, all PCR reactions produced one band of the expected size for wild-type mRNA transcript containing exons 9 and 10 ( Figure 3B ).
As positive controls, hybrid minigenes containing either a T5 or a T3 allele showed a significant decrease of correctly spliced transcript with the appearance of an aberrantlyspliced transcript containing only the exon 10. As previously reported 35 , the same constructs with variable size containing (TAAA) n motif were also created to ensure that enclosed sequences to the motif repeats do not contain silencer or enhancer elements. No modulation of the spliced transcript has been observed (data not shown). Our findings indicated that the (TAAA) 6 and (TAAA) 8 repeats has no effect on exon 10 splicing.
The (TAAA) n repeat motif alters the CFTR transcription
In a second set of experiments, we speculated that the variation in the (TAAA) number might alter the activity of the CFTR promoter as previously reported for other genes. 16 34 To explore this possibility, we transfected in both HVP and Hela cells, pGL3-Control reporter vectors containing the (TAAA) 9 , (TAAA) 8 or (TAAA) 6 allele [pGL3C-(TAAA) n ] as shown in Figure 4A . The results showed that in HVP cells, the pGL3C-(TAAA) 6 and pGL3C-(TAAA) 8 13 plasmids significantly decreased the luciferase level. Interestingly, a decrease in repeat number from 9 to 8 and from 9 to 6 resulted in an inhibition of luciferase activity to 45 and 50% respectively ( Figure 4A, left panel) . In Hela cells, the presence of either the (TAAA) 6 To judge the FOXI1 binding ability on the (TAAA) n repeats, qChIP assays were performed using HVP cells stably transfected with (TAAA) 9 , (TAAA) 8 , or (TAAA) 6 allele.
Quantitative PCR realized with specific primers for a 350 bp-region encompassing the (TAAA) n repeat, revealed that the FOXI1 proteins bind to these intronic sequences ( Figure   5C ). Interestingly, we observed an increasing binding activity associated with the loss of (TAAA) repeats. Although our findings evidenced that the FOXI1 transcription factor negatively influenced the CFTR transcription, this attenuation seems to be independent of the loss of (TAAA) repeats suggesting that the CFTR repression is mediated by another unknown molecular mechanism.
Discussion
Because polymorphisms in the promoter region may modulate gene transcription by interacting with trans-acting elements, we set out functional analyses including in silico analyses, promoter reporter assays, and ChIP experiments, to explore the role of the -33G>A nucleotide change in promoter activity.
We demonstrated that the -33A allele inhibits significantly the CFTR promoter activity 15 and alters the binding of the FOXI1 trans-acting factor and that the enforced FOXI1 protein expression negatively modulates the CFTR transcription. As FOXI1 proteins are here described as repressors for the first time, we confirmed our data by using reporter vectors containing promoter sequences of genes known to be positively transactivated by FOXI1. 30 32 Interestingly, the inhibitory effect of FOXI1 is stronger on the -33A allele than on the wildtype allele. Our findings suggest the contribution of FOXI1 in the physiopathology of CBAVD disorder through alteration of the CFTR promoter activity. The winged helix/forkhead box (FOX) gene family encodes a large class of nuclear proteins, characterized by a highly conserved forkhead DNA-binding domain. 37 The FOX proteins are involved in a wide range of developmental processes through regulation of tissue-specific expression of target genes during morphogenesis and differentiation. 38 39 Among the FOX transcription factors, recent attention have been drawn to FOXI1 (also known as HFH3, Fkh10 and FREAC6). Although FOXI1 was originally identified as a kidney-expressed forkhead gene [40] [41] [42] , recent data indicated its pivotal regulatory role for normal sperm function. 30 31 Blomqvist and collaborators showed that mice lacking FOXI1 fail to generate offspring. FOXI1 has been reported to function as a regulator of genes, important for the epididymal dependent maturation and storage of spermatozoa. 30 In parallel, we provided experimental evidences showing that the (TAAA) n repeat sequence within the CFTR intron 9 has a functional role in the CFTR transcriptional regulation by using gene reporter assays, confirmed by CFTR mRNA expression.
Microsatellites have been described to alter the activity of genes when located in the promoter 15 34 or in introns. 16 33 In addition, Phylactides and coll. have previously reported that cis-acting elements located deep within CFTR introns promote the CFTR expression. 43 To determine the molecular mechanism that might explain the transcriptional impact of the STR, 
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